Patent details

EP2211849 Title: Dexanabinol with inhibitors of BRAF or MEK for the treatment of melanoma.

Basic Information

Publication number:
EP2211849
PCT Application Number:
PCT/GB/2008/003415
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP088379573
PCT Publication Number:
WO/2009/047505
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Dexanabinol with inhibitors of BRAF or MEK for the treatment of melanoma.
French Title of Invention:
Traitement de mélanome.
German Title of Invention:
Dexanabinol mit BRAF- oder MEK-Inhibitoren zur Behandlung von Melanom.
SPC Number:

Dates

Filing date:
10/10/2008
Grant date:
17/07/2013
EP Publication Date:
17/07/2013
PCT Publication Date:
16/04/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2010
EP B1 Publication Date:
17/07/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/10/2013
Expiration date:
10/10/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/10/2008
 
 

Name:
E-Therapeutics plc
Address:
17 Blenheim Office Park, Long Hanborough Oxfordshire OX29 8LN, United Kingdom (GB)

Inventor

1

Name:
THOMAS Catherine, Mary
Address:
United Kingdom (GB)

2

Name:
YOUNG Malcolm, Philip
Address:
United Kingdom (GB)

3

Name:
CHARLTON Julie Anne
Address:
United Kingdom (GB)

4

Name:
IDOWU Olusola, Clement
Address:
United Kingdom (GB)

Priority

Priority Number:
0719771
Priority Date:
10/10/2007
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/166;
Filing date Document type Number of pages